About Us

QuantHealth is a pioneering AI-driven healthcare company transforming drug development through its advanced clinical trial simulations

1738000215-img_6838-1

Quant What?

Founded in 2020, QuantHealth has successfully simulated over 350 clinical trials with an impressive 85% accuracy.

 

Its cutting-edge in-silico platform enables pharmaceutical and biotechnology companies to accelerate and de-risk their development processes.
1733315279-222

Redefining Clinical Development

Trusted by many of the world's top 50 pharmaceutical companies, QuantHealth's technology predicts how any patient will respond to any treatment, supporting smarter trial planning, indication selection, drug in-licensing, and portfolio optimization. By generating synthetic evidence across all clinical phases, QuantHealth is shaping the future of healthcare.

Our Vision

At QuantHealth, our vision is to transform the future of healthcare by accelerating the development of groundbreaking therapies. We are committed to bringing more and better treatments to patients worldwide, faster and more affordably than ever before. Paving the way for a healthier, more hopeful future.

By the Numbers

>10K

Data points per patient
Over


600

Trials simulated
Over


45

Diseases

85%

Endpoint prediction accuracy

>100K

Drug & mechanism data points

350M


Lives

Our Award-Winning Platform

  • 1737466955-award-4

    CB Insights

  • 1737466955-award-5

    Frost & Sullivan

  • 1737466955-award-6

    Fast Company

  • 1738062822-2024_inc-best_in_business_standard_logo

    Inc. Best In Business

  • 1737466955-award-1

    AstraZeneca

  • 1737466955-award-7

    BARDA

  • 1737466955-award-2

    Israel Innovation Authority

  • 1737466955-award-3

    PLUG AND PLAY

Proud to Partner with

  • 1738601208-3
  • 1738601208-2
  • 1738601208-1
  • 1733239274-image-3
  • 1738601355-5
  • 1738601355-6

Proudly Supported by

  • 1733238970-image-321
  • 1733239224-image
  • 1733239253-image-1
  • 1733239274-image-3
  • 1733239264-image2
  • 1740315383-160-x-80
  • 1774277248-unknown-edited-2

Leadership

At QuantHealth, our team embodies a remarkable fusion of talent, expertise, and dedication. Comprising a large and diverse group of professionals, we bring together specialists from a wide array of disciplines, including data science, biology, medicine, bioinformatics, mathematics, software engineering, product management, immunology, pharmacology, and epidemiology.

Our team members boast backgrounds from leading academic institutions and top-tier industry roles, ensuring that we operate at the forefront of innovation and excellence. With 36% of our team holding PhDs or MDs and 75% possessing advanced degrees, we are not just highly qualified—we are passionate about what we do. Known for being exceptionally nice, incredibly dedicated, and unfailingly professional, our team is united by a common goal: to revolutionize healthcare and make a profound impact on the future of medicine.

Orr
Inbar
Co founder & Chief Executive Officer
1731015602-orr-inbar Open Orr Inbar profile on LinkedIn
Arnon
Horev
Co founder & Chief Strategy & Operations
1731015602-arnon-horev Open Arnon Horev profile on LinkedIn
Adam
Goldberger
Chief Financial Officer
1731015603-adam-goldberger Open Adam Goldberger profile on LinkedIn
Francisco
Beca, MD, PhD
Chief Medical Officer
1781703297-beca
Nadav
Weinberg
SVP, Sales
1774272773-untitled-design-5 Open Nadav Weinberg profile on LinkedIn
David
Dornstreich
Chief Commercial Officer
1731015603-david-dornstreich Open David Dornstreich profile on LinkedIn

QuantHealth in the Press

QuantHealth Whitepaper Tile-selection

Decision Intelligence is the Next Transformation in Drug Development

July 20, 2026

Sustaining this momentum in a fast-moving environment depends on three things: proving real value, mobilizing the surrounding ecosystem, and shifting the relationship between human experts and AI systems.
Read More
48

The Israeli startups to watch out for in 2026

May 13, 2026

Read More
46

Newsweek AI Impact Awards

May 08, 2026

Read More
45

Wave of AI and data science tools set to transform clinical trials

April 30, 2026

Read More
44

Why AI maker Anthropic’s deal with Coefficient Bio could be a pharma turning point

April 28, 2026

Read More
43

The startup QuantHealth claims it can predict how any patient will respond to any therapy, even novel ones

April 27, 2026

Read More
42

Non-animal testing goes mainstream, but success hinges on smart use

April 23, 2026

Read More
40

Changing Faces: Digital and supplier, March 2026

April 20, 2026

Read More
41

AI Platform Predicts Clinical Trial Outcomes with High Accuracy

April 20, 2026

Read More
1737562159-pharma-research

20 Pharmaceutical Companies in Israel to Know

December 23, 2024

Israeli pharmaceutical companies are leveraging biotech and synthetics to craft modern drugs and therapies for numerous health conditions
Read More
1737562096-960x0-1

Why Breaking Into Healthcare Is So Hard—How To Overcome The Barrier

December 09, 2024

The healthcare industry is like a fortress in more ways than one. Being the first and last line of defense when it comes to our wellbeing places a unique pressure on the industry to stick with what works, which is why breakthroughs, such as new drugs, can take decades to get from the lab to end users. It’s an industry where mistakes can cost lives, and failing fast, or failing at all for that matter, isn’t an option.
Read More
1737560393-gettyimages-1261086485

QuantHealth brings its AI-informed clinical drug trials to the US with $15M round

August 30, 2024

Biotech, pharmaceutical and life sciences companies all hope AI will streamline drug development and make it more efficient, and 38% have already adopted the technology, according to Deloitte. QuantHealth aims to take part with a model that predicts risks and outcomes for clinical trials.
Read More
1737561997-2024-mic-article-europe-middle-east-and-africa-05-1

This startup uses AI to simulate clinical trials and speed new drugs to market

March 24, 2024

Tel Aviv-based QuantHealth is one of Fast Company’s Most Innovative Companies in Europe, the Middle East, and Africa for 2024.
Read More
1736272863-press-release-1

Six Israeli startups selected to participate in BeyondBio SCALE program

December 18, 2022

Improving cancer treatment, enabling efficient ways for sharing of data for advanced research, and AI for predicting drug safety, are all among the innovative solutions developed by the six startups selected for BeyondBio SCALE - a joint innovation program of AstraZeneca, Accenture, Clalit and AWS
Read More